Uceris Ulcerative Colitis Brand Landscape provides detailed analysis of Uceris’s impact on the UC market. This brand navigator report on Uceris provides an in-depth look at a key treatment for ulcerative colitis patients. With Uceris ulcerative colitis patients have a critical tool to treat not only their flares but also potentially provide a long-term solution.
It also includes insights gathered directly from US gastroenterologists. No other market research report available includes as much in-depth information about Uceris, it’s clinical brand attributes, target patient profile, competitive outlook and much more.
This primary research report allows you to identify Uceris’s clinical strengths and weaknesses compared to competitor treatments. With the Uceris Ulcerative Colitis Brand Landscape, you’ll have:
- Insights from more than 125 US gastroenterologists
- A robust analysis of Uceris’s brand value
- A deep understanding of its place in the UC marketplace
- HCP perceptions and prescribing habits for Uceris
Strategic Questions Answered about the Uceris Ulcerative Colitis Brand Landscape
- Rx trends: Do physicians expect future Remicade usage to increase vs. decrease?
- Patient selection: What characteristics identify typical Remicade patients?
- Competitive landscape: Which brands compete most often with Remicade?
- Clinical perceptions: How do physicians perceive Remicade’s clinical profile?
- Brand persona: How do physicians perceive Remicade’s brand persona?
Summary of Strategic Insights from Uceris Ulcerative Colitis Brand Landscape
- Though prescribed to a smaller population of patients, Uceris is used for patients who have mild or mild to moderate disease.
- Prednisone is Uceris’ number one competitor. Among branded drugs, Zeposia is its top competition.
- Tolerability is one of Uceris’ core strengths compared to other UC brands.
Benefits of Purchasing the Uceris Ulcerative Colitis Brand Landscape
- Cost-efficient insights about how Uceris’ position in the ulcerative colitis market impacts your strategic marketing decisions.
- Insights drawn from in-depth interviews among global KOLs and surveys of more than 125 gastroenterologists
- A complimentary 30-minute workshop with you (and your team)
- Unlimited support from Vivisum’s ulcerative colitis strategist for 1-year.
Table of Contents
Uceris through the PHYCURE Lens – 5
Clinical Brand Attributes – 6
- Most Ideal UC Brands – 7
- Least Ideal UC Brands – 8
- Most Efficacious UC Brands – 9
- Least Efficacious UC Brands – 10
- Most Favorable Safety Profile Among UC Brands – 11
- Least Favorable Safety Profile Among UC Brands – 12
- Easiest Dosing Among UC Brands – 13
- Most Challenging Dosing Among UC Brands – 14
- Best Tolerability Among UC Brands – 15
- Worst Tolerability Among UC Brands – 16
- Best Access Among UC Brands – 17
- Worst Access Among UC Brands – 18
- Best Support Among UC Brands – 19
- Worst Support Among UC Brands – 20
Uceris Patient Profile – 21
- Uceris ‘Typical’ Patient Summary – 22
- Uceris Patient: ‘Typical’ Disease Severity – 23
- Uceris Patient: ‘Typical’ Treatment History – 24
- Uceris Patient: ‘Typical’ Lifestyle – 25
- Uceris Patient: ‘Typical’ Treatment Adherence – 26
- Uceris Patient: ‘Typical’ Comorbidities – 27
Uceris Top Brand Competitors – 28
- Uceris’ Top Competitors – 29
- Uceris Brand Competitor Prescribing Patterns – 30
- Uceris Competitor Emotional Brand Personalities – 31
- Uceris Brand Competitor Rational Perceptions – 32
- Uceris Brand Competitor Target Patient Profile – 33
Uceris Clinical Brand Profile – 34
- Analysis of Uceris as an Ideal Brand – 35
- Uceris Strengths – 36
- Uceris Weaknesses – 37
- Uceris Summary – 38
Uceris Brand Personality – 39
- Uceris Brand Personalities – 40
- Uceris: Rebel Personality – 41